BioCentury
ARTICLE | Company News

GPC Biotech in alliance with Aventis

December 15, 2000 8:00 AM UTC

GPC will use its PathCode technology protein interaction mapping technology to identify and validate proteins that interact with one of AVE's drug discovery targets. Separately, the companies are coll...